This filing is a standard roadshow announcement with no trading catalyst. Monitor for future material updates such as clinical trial results or financial filings.
Price Chart
Executive Summary
Immuron filed a 6-K announcing that CEO Steven Lydeamore will present at the TechKnow Invest Roadshow on July 27, 2026. The attached presentation contains no new material information—only a general overview of the company's pipeline (Travelan, IMM-529, ProIBS) and platform technology. This is a routine investor relations activity with no financial data, guidance, or catalysts.
Key Facts
- CEO Steven Lydeamore presenting at TechKnow Invest Roadshow on July 27, 2026 in Melbourne.
- No new financial results, clinical data, regulatory decisions, or material agreements disclosed.
- Presentation reiterates existing product descriptions for Travelan, IMM-529, and ProIBS.
Financial Impact
No financial impact; routine investor relations event.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-079777 |
| Document: ea0298659-6k_immuron.htm | 0001213900-26-079777 |
| Document: 0001213900-26-079777-index-headers.html | 0001213900-26-079777 |
| Document: 0001213900-26-079777-index.html | 0001213900-26-079777 |
| Document: 0001213900-26-079777.txt | 0001213900-26-079777 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $0.9300 | awaiting T+60 | — | $0.9302 (+0.02%) |
Oct 23, 2026 4d ago | 6-K | $0.9200 | awaiting T+60 | — | $0.9302 (+1.11%) |
Oct 23, 2026 4d ago | 424B5 | $0.9200 | awaiting T+60 | — | $0.9302 (+1.11%) |
Oct 21, 2026 5d ago | 6-K | $0.9490 | awaiting T+60 | — | $0.9302 (−1.98%) |
Oct 16, 2026 11d ago | 6-K | $0.9821 | awaiting T+60 | — | $0.9302 (−5.28%) |
Oct 13, 2026 14d ago | 6-K | $1.04 | awaiting T+60 | — | $0.9302 (−10.56%) |
Sep 24, 2026 4w ago | 20-F | $1.19 | awaiting T+60 | — | $0.9302 (−21.83%) |
Sep 24, 2026 4w ago | 6-K | $1.19 | awaiting T+60 | — | $0.9302 (−21.83%) |
Sep 21, 2026 5w ago | 6-K | $1.26 | awaiting T+60 | — | $0.9302 (−25.88%) |
Sep 4, 2026 7w ago | Press Release | $1.80 | awaiting T+60 | — | $0.9302 (−48.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers